Seehra Jasbir

CIK 00017323692 companiesLEXINGTON, MA

SEC Profile

Transactions

Companies

Filings

CIK

0001732369

Recent Transactions

25 trades

Award
Keros Therapeutics, Inc.$KROS
Employee Stock Option (Right to Buy)
2026-02-24+217,000→ 217,000 total
Award
Keros Therapeutics, Inc.$KROS
Employee Stock Option (right to buy)
2026-02-24+100,000→ 100,000 total
Sale
Keros Therapeutics, Inc.$KROS
Common Stock
2026-02-19$16.17/sh−7,015→ 385,708 total
Award
Keros Therapeutics, Inc.$KROS
Employee Stock Option (right to buy)
2026-01-07+62,500→ 62,500 total
Award
Keros Therapeutics, Inc.$KROS
Common Stock
2025-09-03+90,500→ 392,723 total
Exercise/Conversion
Keros Therapeutics, Inc.$KROS
Common Stock
2025-04-04$0.30/sh+49,367→ 302,223 total
Exercise/Conversion
Keros Therapeutics, Inc.$KROS
Employee Stock Option (right to buy)
2025-04-04−49,367→ 252,444 total
Award
Keros Therapeutics, Inc.$KROS
Employee Stock Option (right to buy)
2024-02-23+125,000→ 125,000 total
Award
Keros Therapeutics, Inc.$KROS
Employee Stock Option (right to buy)
2024-02-13+125,000→ 125,000 total
Exercise/Conversion
Keros Therapeutics, Inc.$KROS
Employee Stock Option (right to buy)
2023-04-08−4,000→ 45,087 total
Exercise/Conversion
Keros Therapeutics, Inc.$KROS
Common Stock
2023-04-08$0.48/sh+4,000→ 252,856 total
Award
Keros Therapeutics, Inc.$KROS
Employee Stock Option (right to buy)
2023-02-16+200,000→ 200,000 total
Award
Eloxx Pharmaceuticals, Inc.
Stock Options (Right to Buy)
2022-06-15+20,000→ 20,000 total
Exercise/Conversion
Keros Therapeutics, Inc.$KROS
Common Stock
2022-06-09$0.30/sh+5,000→ 248,856 total
Exercise/Conversion
Keros Therapeutics, Inc.$KROS
Employee Stock Option (right to buy)
2022-06-09−5,000→ 8,822 total
Award
Keros Therapeutics, Inc.$KROS
Employee Stock Option (right to buy)
2022-01-21+165,000→ 165,000 total
Award
Eloxx Pharmaceuticals, Inc.
Stock Option (Right to Buy)
2021-05-19+20,000→ 20,000 total
Award
Keros Therapeutics, Inc.$KROS
Employee Stock Option (right to buy)
2021-01-10+127,200→ 127,200 total
Award
Eloxx Pharmaceuticals, Inc.
Stock Option (Right to Buy)
2020-05-20+20,000→ 20,000 total
Purchase
Keros Therapeutics, Inc.$KROS
Common Stock
2020-04-13$16.00/sh+20,000→ 243,856 total
Conversion
Keros Therapeutics, Inc.$KROS
Common Stock
2020-04-13+11,169→ 223,856 total
Conversion
Keros Therapeutics, Inc.$KROS
Series C Preferred Stock
2020-04-13−11,169→ 0 total
Award
Keros Therapeutics, Inc.$KROS
Employee Stock Option (right to buy)
2020-04-07+696,569→ 696,569 total
Award
Eloxx Pharmaceuticals, Inc.
Stock Option (Right to Buy)
2019-05-29+20,000→ 20,000 total
Award
Eloxx Pharmaceuticals, Inc.
Stock Option (Right to Buy)
2018-06-15+40,000→ 40,000 total

Companies

Recent Filings

Address

C/O KEROS THERAPEUTICS, INC. 1050 WALTHAM STREET, SUITE 302

LEXINGTON, MA, 02421

View on SEC.gov